home / stock / aldx / aldx quote
Last: | $3.19 |
---|---|
Change Percent: | 0.0% |
Open: | $3.2 |
Close: | $3.19 |
High: | $3.2 |
Low: | $3.1 |
Volume: | 221,582 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.19 | $3.2 | $3.19 | $3.2 | $3.1 | 221,582 | 07-05-2024 |
$3.2 | $3.22 | $3.2 | $3.3 | $3.15 | 164,575 | 07-04-2024 |
$3.2 | $3.22 | $3.2 | $3.3 | $3.15 | 164,575 | 07-03-2024 |
$3.25 | $3.28 | $3.25 | $3.29 | $3.16 | 238,595 | 07-02-2024 |
$3.25 | $3.28 | $3.25 | $3.38 | $3.21 | 295,450 | 07-01-2024 |
$3.31 | $3.41 | $3.31 | $3.4599 | $3.29 | 2,213,761 | 06-28-2024 |
$3.4 | $3.25 | $3.4 | $3.47 | $3.25 | 211,642 | 06-27-2024 |
$3.25 | $3.29 | $3.25 | $3.347 | $3.17 | 390,358 | 06-26-2024 |
$3.33 | $3.27 | $3.33 | $3.39 | $3.26 | 256,192 | 06-25-2024 |
$3.29 | $3.53 | $3.29 | $3.56 | $3.29 | 260,568 | 06-24-2024 |
$3.48 | $3.4 | $3.48 | $3.55 | $3.39 | 321,560 | 06-21-2024 |
$3.395 | $3.59 | $3.395 | $3.6 | $3.14 | 595,449 | 06-20-2024 |
$3.63 | $3.68 | $3.63 | $3.8 | $3.59 | 429,419 | 06-19-2024 |
$3.63 | $3.68 | $3.63 | $3.8 | $3.59 | 429,419 | 06-18-2024 |
$3.68 | $3.75 | $3.68 | $3.77 | $3.65 | 336,519 | 06-17-2024 |
$3.73 | $3.82 | $3.73 | $3.88 | $3.65 | 396,962 | 06-14-2024 |
$3.86 | $3.94 | $3.86 | $4.05 | $3.84 | 162,056 | 06-13-2024 |
$3.89 | $3.87 | $3.89 | $4.045 | $3.845 | 377,735 | 06-12-2024 |
$3.77 | $3.83 | $3.77 | $3.87 | $3.76 | 342,937 | 06-11-2024 |
$3.87 | $3.85 | $3.87 | $3.885 | $3.77 | 197,263 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
Live Webcast Scheduled to Begin at 8:00 a.m. ET Today Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced advancement of new ...
Clinical Trial Results and Potential New Drug Application Resubmission Expected in the Second Half of 2024 Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabo...
Event Scheduled for Thursday, June 20 at 8:00 a.m. ET Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that the company will h...